NSAID-associated lesions of the gastrointestinal tract and their complications: ways of preventing
- Authors: Pakhomova I.G.1
-
Affiliations:
- I.I.Mechnikov State Northwestern Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 19, No 9 (2017)
- Pages: 109-113
- Section: Articles
- URL: https://journal-vniispk.ru/2075-1753/article/view/94938
- DOI: https://doi.org/10.26442/2075-1753_19.9.109-113
- ID: 94938
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
I. G. Pakhomova
I.I.Mechnikov State Northwestern Medical University of the Ministry of Health of the Russian Federation
Email: pakhomova-inna@yandex.ru
канд. мед. наук, доц. каф. пропедевтики внутренних болезней, гастроэнтерологии и диетологии 191015, Russian Federation, Saint Petersburg, ul. Kirochnaia, d. 41
References
- Гельфанд Б.Р., Проценко Д.Н., Бабаянц А.В., Каратеев А.Е. Острые кровотечения из верхних отделов желудочно-кишечного тракта: от эпидемиологии до формирования концепции консервативной терапии. Инфекции в хирургии. 2013; 4: 11-7.
- Harirforoosh S, Asghar W, Jamali F. Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications. J Pharm Pharm Sci (www.cspsCanada.org) 2013; 16 (5): 821-47.
- Насонов Е.Л., Каратеев А.Е. Поражения желудка, связанные с приемом нестероидных противовоспалительных препаратов. Клин. медицина. 2000; 3, 4: 4-10.
- Singh G, Lanes S, Triadafilopoulos G. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Am J Med 2004; 117 (2): 100-6.
- Lanas A, García-Rodríguez L.A, Polo-Tomás M. et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009; 104: 1633-41.
- Goldstein J.L, Silverstein F.E, Agrawal N.M. et al. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 2000; 95: 1681-90.
- Pincus Т, Swearingen C, Cummins P. at al. Preference for nonsteroidal anti-inflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthri-tis. J Rheumatol 2000; 27: 1020-7.
- Lanas A. et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005; 100: 1685-93.
- Hawkey C.J, Lanas A.I. Doubt and certainty about non-steroidal anti-inflammatory drug in the year 2000: a multidisciplinary expert statement. Am J Med 2001; 8 (110): 79-100.
- Garcia-Rodriguez L.A. Risk of hospitalisation for upper gastrointestinal tract bleeding associated with Ketorolac, other NSAIDs, calcium antagonists, and other antihypertensive drugd. Arch Intern Med 1998; 158: 33-9.
- Yeomans N.D, Lanas A.I, Talley N.J. et al. Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin. Aliment Pharmacol Ther 2005; 22: 795-801.
- Meade T.W. Oral anticoagulants in the secondary and primary prevention of myocardial infarction and coronary death. In: Oral Anticoagulants. Eds: Poller L, Hirsh J. Arnold. London: Hodder Headline Group, 1996: р. 132-42.
- Каратеев А.Е., Насонов Е.Л., Яхно Н.Н. и др. Клинические рекомендации «Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике». Современ. ревматология. 2015; 1: 4-23.
- Насонов Е.Л. Эффективность и переносимость нестероидного противовоспалительного препарата. Нимесулид: новые данные. РМЖ. 2001; 15: 6-8
- Rainsford K. Nimesulide - a multifactorial approach to inflammation and pain: scientific and. clinical consensus. Curr Med Res Opin 2006; 22 (6): 1161-79.
- Conforti A, Leone R, Moretti U. et al. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area. Drug Saf 2001; 24: 1081-90.
- Yeomans N.D, Tulassay Z, Juhasz L. et al. A comparison of omeprazole with ranitidine for ulcers associatedwith non-steroidal anti-inflammatory drugs. N Engl J Med 1998; 338: 719-26.
- Маев И.В., Казюлин А.Н. Использование ребамипида в качестве цитопротективного и противовоспалительного средства при энтеропатиях, индуцированных нестероидными противовоспалительными препаратами. Consilium Medicum. 2016; 18 (8): 8-12
- Malfertheiner P, Megraud F., O’Morain C.A. et al. Management of Helicobacter pylori infection - the Maastricht I.V. Florence Consensus Report. Gut 2016; 0: 1-24.
- Lehmann F.S, Beglinger C. Impact of COX-2 inhibitors in common clinical practice a gastroenterologist's perspective. Curr Top Med Chem 2005; 5 (5): 449-64.
- Davies N.M, Saleh J.Y, Skjodt N.M. Detection and prevention of NSAID-induced enteropathy. J Pharm Pharm Sci 2000; 3 (1): 137-55.
Supplementary files
